Patents Assigned to STEMDR INC.
  • Publication number: 20230248682
    Abstract: The present disclosure relates to a composition for preventing, alleviating or treating pruritus and/or atopy using an N-acetylamino acid or an N-acylamino acid having almost no side effects on the human body. Also, the present disclosure relates to a cosmetic composition for moisturizing skin or soothing skin. The composition of the present disclosure may be utilized to ameliorate a problematic skin condition caused by various causes, or to safely and effectively alleviate or treat pruritus and/or atopy without concern about side effects.
    Type: Application
    Filed: March 23, 2023
    Publication date: August 10, 2023
    Applicants: STEMDR INC., INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY, KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Myung-Kwan HAN, Kwangho LEE
  • Publication number: 20220233485
    Abstract: The present disclosure relates to a composition for preventing, alleviating or treating pruritus and/or atopy using an N-acetylamino acid or an N-acylamino acid having almost no side effects on the human body. Also, the present disclosure relates to a cosmetic composition for moisturizing skin or soothing skin. The composition of the present disclosure may be utilized to ameliorate a problematic skin condition caused by various causes, or to safely and effectively alleviate or treat pruritus and/or atopy without concern about side effects.
    Type: Application
    Filed: February 10, 2022
    Publication date: July 28, 2022
    Applicants: STEMDR INC., INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY, KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Myung-Kwan HAN, Kwangho LEE
  • Publication number: 20220233502
    Abstract: The present disclosure relates to a composition for preventing, alleviating or treating asthma, rhinitis and/or conjunctivitis using an N-acylamino acid, which has almost no side effect on the human body. The composition of the present disclosure has an excellent effect of alleviating the symptoms of asthma by exhibiting alleviation effects on both inflammatory response in the airway and airway fibrosis, which are major clinical symptoms of asthma, and thus can be effectively used in drugs or foods for alleviating asthma. In addition, it can be usefully used in drugs or foods for alleviating rhinitis and conjunctivitis since it significantly alleviates the clinical symptoms of rhinitis and conjunctivitis.
    Type: Application
    Filed: May 21, 2020
    Publication date: July 28, 2022
    Applicant: STEMDR INC.
    Inventors: Myung-Kwan HAN, Kwangho LEE
  • Publication number: 20210308096
    Abstract: The present disclosure relates to a composition for preventing, improving or treating pruritus by using a naturally derived ingredient. The composition of the present disclosure may be used to improve or treat pruritus caused by various causes safely and effectively without the risk of side effects.
    Type: Application
    Filed: June 18, 2021
    Publication date: October 7, 2021
    Applicants: INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY, STEMDR INC.
    Inventors: Myung-Kwan HAN, Hern-Ku LEE, So-Jeong KIM, Suhn-Young IM, Baik-Hwan CHO, Jeong-Soo PARK
  • Publication number: 20200316001
    Abstract: The present disclosure relates to a composition for preventing, alleviating or treating pruritus and/or atopy using an N-acetylamino acid or an N-acylamino acid having almost no side effects on the human body. Also, the present disclosure relates to a cosmetic composition for moisturizing skin or soothing skin. The composition of the present disclosure may be utilized to ameliorate a problematic skin condition caused by various causes, or to safely and effectively alleviate or treat pruritus and/or atopy without concern about side effects.
    Type: Application
    Filed: November 23, 2018
    Publication date: October 8, 2020
    Applicants: STEMDR INC., INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY, KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventor: Myung-Kwan HAN
  • Publication number: 20200030283
    Abstract: The present disclosure relates to a composition for preventing, improving or treating pruritus by using a naturally derived ingredient. The composition of the present disclosure may be used to improve or treat pruritus caused by various causes safely and effectively without the risk of side effects.
    Type: Application
    Filed: December 12, 2017
    Publication date: January 30, 2020
    Applicants: INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY, STEMDR INC.
    Inventors: Myung-Kwan HAN, Hern-Ku LEE, So-Jeong KIM, Suhn-Young IM, Baik-Hwan CHO, Jeong-Soo PARK
  • Patent number: 9913880
    Abstract: The present invention relates to a composition containing an inducer of SIRT1 (silent mating type information regulation 2 homolog) expression for preventing or treating sepsis or septic shock. The inducer of SIRT1 expression can remarkably reduce the mortality caused by sepsis or septic shock by reducing pro-inflammatory cytokines and increasing anti-inflammatory cytokines. Therefore, the inducer of SIRT1 expression is useful for preventing or treating sepsis or septic shock.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: March 13, 2018
    Assignee: STEMDR INC.
    Inventors: Myung Kwan Han, Chae Hwa Yoo, Eun Kyung Song, Seung Ok Lee